Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of the National Cancer Institute
|
November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Sarah E S Leary, Julie R Park, Joel M Reid, et al.
Pediatric Blood & Cancer
|
September 27, 2014
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium
Stephan D Voss, Julia Glade-Bender, Sheri L Spunt, et al.
Pediatric Blood & Cancer
|
March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study
Maryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2016
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward
Joanne P Lagmay, Mark D Krailo, Ha Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group
Suman Malempati, Brenda Weigel, Ashish M Ingle, et al.
Pediatric Blood & Cancer
|
June 7, 2023
A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosis
Aaron R Weiss, Sarah Dry, Clara Maygar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescents
Andrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of the National Cancer Institute
|
November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Sarah E S Leary, Julie R Park, Joel M Reid, et al.
Pediatric Blood & Cancer
|
September 27, 2014
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium
Stephan D Voss, Julia Glade-Bender, Sheri L Spunt, et al.
Pediatric Blood & Cancer
|
March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study
Maryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2016
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward
Joanne P Lagmay, Mark D Krailo, Ha Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group
Suman Malempati, Brenda Weigel, Ashish M Ingle, et al.
Pediatric Blood & Cancer
|
June 7, 2023
A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosis
Aaron R Weiss, Sarah Dry, Clara Maygar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescents
Andrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
Page
of 5